BRIEF published on 06/05/2026 at 22:20, 17 days 5 hours ago Monthly publication of Nanobiotix voting rights Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
BRIEF published on 06/02/2026 at 22:35, 20 days 5 hours ago Nanobiotix: Review of the first quarter of 2026 Biotechnology Clinical Trials Capital Increase Nanotechnology NBTXR3
BRIEF published on 06/02/2026 at 22:35, 20 days 5 hours ago Nanobiotix Reports Q1 2026 Operational and Financial Progress NSCLC Financial Update NANOBIOTIX JNJ-1900 AACR 2026
PRESS RELEASE published on 06/02/2026 at 22:30, 20 days 5 hours ago Nanobiotix Provides First Quarter 2026 Operational and Financial Update Nanobiotix provides operational and financial update for Q1 2026, including successful fundraising and clinical study advancements in cancer treatment Cancer Treatment Clinical Study Financial Update NANOBIOTIX Q1 2026
BRIEF published on 06/02/2026 at 08:35, 20 days 19 hours ago Nanobiotix joins the Euronext Tech Leaders index Innovation Investors Biotechnology NANOBIOTIX Euronext Tech Leaders
BRIEF published on 06/02/2026 at 08:35, 20 days 19 hours ago Nanobiotix Joins Euronext Tech Leaders Index Innovation Biotechnology Healthcare NANOBIOTIX Euronext Tech Leaders
PRESS RELEASE published on 06/02/2026 at 08:30, 20 days 19 hours ago Nanobiotix Joins the Euronext Tech Leaders Index Nanobiotix joins the Euronext Tech Leaders Index, a move recognizing its contributions to nanotechnology in healthcare innovation and expanding treatment options for cancer patients Cancer Treatment Healthcare Innovation Nanotechnology NANOBIOTIX Euronext Tech Leaders Index
BRIEF published on 05/26/2026 at 23:04, 27 days 4 hours ago NANOBIOTIX Completes Global Offering with $100 Million Proceeds Securities Biotechnology Investment Global Offering NANOBIOTIX
PRESS RELEASE published on 05/26/2026 at 22:59, 27 days 5 hours ago NANOBIOTIX Announces Closing of Global Offering Nanobiotix closes global offering with total gross proceeds of $100 million. Proceeds to fund development and corporate purposes. Ordinary shares and ADSs issued Development ADSs Proceeds Global Offering NANOBIOTIX
BRIEF published on 05/22/2026 at 22:20, 1 month ago NANOBIOTIX raises $100 million through a global offering Biotechnology Fundraising Ads Cancer NANOBIOTIX
Published on 06/23/2026 at 01:55, 2 hours 4 minutes ago Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/22/2026 at 23:25, 4 hours 34 minutes ago Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/22/2026 at 23:05, 4 hours 54 minutes ago Gamma Resources Settles Remaining Balance of Outstanding Debt
Published on 06/22/2026 at 21:05, 6 hours 54 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 8 hours 14 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/23/2026 at 01:35, 2 hours 24 minutes ago DoH and Sanofi Partner to Advance Vaccine Innovation
Published on 06/22/2026 at 21:07, 6 hours 52 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 7 hours 9 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 7 hours 27 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 8 hours 32 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:00, 9 hours 59 minutes ago GUILLEMOT CORPORATION: STATEMENT REGARDING THE PASSING OF Mr. CLAUDE GUILLEMOT, CHAIRMAN OF GUILLEMOT CORPORATION GROUP
Published on 06/22/2026 at 08:30, 19 hours 29 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
